CLAL INSURANCE ENTERPRISES HOLDINGS LTD. (CLIS)
Max (in parenthesis) published the results of a public tender for the issuance of commercial papers 6
Max (in parenthesis) published the results of a public tender for the issuance of commercial papers 6
Conference call to review the financial statements for 2025 on 30.3.26 at 15:00
The District Court rejected a motion for a class action against subsidiaries regarding the sale of Alrov
Conference call to review the financial statements for 2025 on March 31, 2026 at 14:00
Dormant shares
Events and transactions
Novartis IgAN data in New England Journal of Medicine showFabhalta® slowed kidney function decline by 49.3%
Change in holdings of interested parties/officers
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law Firm
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law Firm